Outstanding breakthroughs
Incorporated in March 2009, Beta Innov SAS pursues the long-term objective of investigating an innovative concept called «Auto-immune Diseases and Tumor Cell Division».
Those decisive breakthroughs concerning orphan and auto-immune diseases present a unique originality deriving from the fact that they are acting at cells and protein level rather than at genomic level.
To achieve this, Beta Innov has set up laboratory facilities within Montpellier Institute for Biotherapy Research (IRB, Hôpital Saint-Éloi) manned by six full time PhD researchers.